Home Healthcare Biotechnology STD Diagnostics Market

STD Diagnostics Market Size, Share & Trends Analysis Report By Products (Instruments and Services, Consumables, Software), By Applications (Chlamydia, Syphilis, Gonorrhoea, Herpes simplex virus, Human papilloma virus, Human immunodeficiency virus, Trichomonas, Urea Plasma and Mycoplasma, Varicella zoster virus), By Technology (Immunoassay, Molecular Diagnostics, Other technology), By Location of testing (Laboratory testing, Point-of-care testing) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 19, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. STD Diagnostics Market, By Products 2022-2034 (USD MILLION/ Units)
    1. Instruments and Services
    2. Consumables
    3. Software
  2. STD Diagnostics Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Chlamydia
    2. Syphilis
    3. Gonorrhoea
    4. Herpes simplex virus
    5. Human papilloma virus
    6. Human immunodeficiency virus
    7. Trichomonas
    8. Urea Plasma and Mycoplasma
    9. Varicella zoster virus
  3. STD Diagnostics Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Immunoassay
    2. Molecular Diagnostics
    3. Other technology
  4. STD Diagnostics Market, By Location of testing 2022-2034 (USD MILLION/ Units)
    1. Laboratory testing
    2. Point-of-care testing
  5. Regional STD Diagnostics Market
    1. North America
      1. North America STD Diagnostics Market By Products 2022-2034 (USD MILLION/ Units)
        1. Instruments and Services
        2. Consumables
        3. Software
      2. North America STD Diagnostics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Chlamydia
        2. Syphilis
        3. Gonorrhoea
        4. Herpes simplex virus
        5. Human papilloma virus
        6. Human immunodeficiency virus
        7. Trichomonas
        8. Urea Plasma and Mycoplasma
        9. Varicella zoster virus
      3. North America STD Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassay
        2. Molecular Diagnostics
        3. Other technology
      4. North America STD Diagnostics Market By Location of testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory testing
        2. Point-of-care testing
      5. U.S.
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      6. Canada
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
    2. Europe
      1. Europe STD Diagnostics Market By Products 2022-2034 (USD MILLION/ Units)
        1. Instruments and Services
        2. Consumables
        3. Software
      2. Europe STD Diagnostics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Chlamydia
        2. Syphilis
        3. Gonorrhoea
        4. Herpes simplex virus
        5. Human papilloma virus
        6. Human immunodeficiency virus
        7. Trichomonas
        8. Urea Plasma and Mycoplasma
        9. Varicella zoster virus
      3. Europe STD Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassay
        2. Molecular Diagnostics
        3. Other technology
      4. Europe STD Diagnostics Market By Location of testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory testing
        2. Point-of-care testing
      5. U.K.
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      6. Germany
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      7. France
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      8. Spain
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      9. Italy
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      10. Russia
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      11. Nordic
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      12. Benelux
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      13. Rest of Europe
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
    3. APAC
      1. APAC STD Diagnostics Market By Products 2022-2034 (USD MILLION/ Units)
        1. Instruments and Services
        2. Consumables
        3. Software
      2. APAC STD Diagnostics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Chlamydia
        2. Syphilis
        3. Gonorrhoea
        4. Herpes simplex virus
        5. Human papilloma virus
        6. Human immunodeficiency virus
        7. Trichomonas
        8. Urea Plasma and Mycoplasma
        9. Varicella zoster virus
      3. APAC STD Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassay
        2. Molecular Diagnostics
        3. Other technology
      4. APAC STD Diagnostics Market By Location of testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory testing
        2. Point-of-care testing
      5. China
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      6. Korea
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      7. Japan
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      8. India
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      9. Australia
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      10. Singapore
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      11. Taiwan
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      12. South East Asia
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      13. Rest of Asia-Pacific
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
    4. Middle East and Africa
      1. Middle East and Africa STD Diagnostics Market By Products 2022-2034 (USD MILLION/ Units)
        1. Instruments and Services
        2. Consumables
        3. Software
      2. Middle East and Africa STD Diagnostics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Chlamydia
        2. Syphilis
        3. Gonorrhoea
        4. Herpes simplex virus
        5. Human papilloma virus
        6. Human immunodeficiency virus
        7. Trichomonas
        8. Urea Plasma and Mycoplasma
        9. Varicella zoster virus
      3. Middle East and Africa STD Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassay
        2. Molecular Diagnostics
        3. Other technology
      4. Middle East and Africa STD Diagnostics Market By Location of testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory testing
        2. Point-of-care testing
      5. UAE
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      6. Turkey
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      7. Saudi Arabia
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      8. South Africa
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      9. Egypt
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      10. Nigeria
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      11. Rest of MEA
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
    5. LATAM
      1. LATAM STD Diagnostics Market By Products 2022-2034 (USD MILLION/ Units)
        1. Instruments and Services
        2. Consumables
        3. Software
      2. LATAM STD Diagnostics Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Chlamydia
        2. Syphilis
        3. Gonorrhoea
        4. Herpes simplex virus
        5. Human papilloma virus
        6. Human immunodeficiency virus
        7. Trichomonas
        8. Urea Plasma and Mycoplasma
        9. Varicella zoster virus
      3. LATAM STD Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassay
        2. Molecular Diagnostics
        3. Other technology
      4. LATAM STD Diagnostics Market By Location of testing 2022-2034 (USD MILLION/ Units)
        1. Laboratory testing
        2. Point-of-care testing
      5. Brazil
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      6. Mexico
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      7. Argentina
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      8. Chile
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      9. Colombia
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
      10. Rest of LATAM
        1. Instruments and Services
        2. Consumables
        3. Software
        4. Chlamydia
        5. Syphilis
        6. Gonorrhoea
        7. Herpes simplex virus
        8. Human papilloma virus
        9. Human immunodeficiency virus
        10. Trichomonas
        11. Urea Plasma and Mycoplasma
        12. Varicella zoster virus
        13. Immunoassay
        14. Molecular Diagnostics
        15. Other technology
        16. Laboratory testing
        17. Point-of-care testing
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.